Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides.
Ortin Global Limited (ORTINGLOBE) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The ORTINGLOBE share price is ₹14.11 (+1.51% today), with a market capitalisation of ₹11Cr. MarketRipple tracks the ORTINGLOBE investment thesis, the ripple-chain impact of market events on Ortin Global Limited, and the Healthcare sector outlook.
Open
₹13.10
High
₹14.32
Low
₹13.10
Prev. Close
₹13.90
52W High
₹21.30
52W Low
₹11.00
Day range
₹13.10–₹14.32
52-week range
₹11.00–₹21.30
Volume
112
P/E
—
ROE
-59.8%
D/E
0.81
Margin
0.0%
Ortin Global Limited (NSE: ORTINGLOBE) is currently trading at ₹14.11 (+1.51%).
Ortin Global Limited's market capitalization is ₹11Cr.
Ortin Global Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).